Responses
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0169 Persistence of Tofacitinib in The Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up To 7 Years
Compose a Response to This Article
Other responses
No responses have been published for this article.